Mechanisms of gefitinib-induced QT prolongation-Reference-Cited by-同舟云学术

Mechanisms of gefitinib-induced QT prolongation

Published:2021-11 Issue: Volume:910 Page:174441
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Jie Ling-Jun,Li Yun-Da,Zhang He-Qiang,Mao Liang,Xie Hua-Bin,Zhou Fa-Guang,Zhou Tian-Li,Xie Dong,Lin Jia-Le,Li Gui-Yang,Cai Bin-Ni,Zhang Yan-Hui,Wang Yan

Publisher

Elsevier BV

Subject

Pharmacology

Reference39 articles.

1. Spironolactone and its main metabolite, canrenoic acid, block human ether-a-go-go-related gene channels;Caballero;Circulation,2003

2. A rapidly activating delayed rectifier K+ current regulates pacemaker activity in adult mouse sinoatrial node cells;Clark;Am. J. Physiol. Heart Circ. Physiol.,2004

3. Experimental design and analysis and their reporting: new guidance for publication in BJP;Curtis;Br. J. Pharmacol.,2015

4. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int. J. Canc.,2010

5. Decreased cardiac L-type Ca(2)(+) channel activity induces hypertrophy and heart failure in mice;Goonasekera;J. Clin. Invest.,2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in understanding cardiotoxicity of EGFR- TKIs in non-small cell lung cancer treatment and beyond;Frontiers in Pharmacology;2024-08-15

2. A biomimetic ion channel shortens the QT interval of type 2 long QT syndrome through efficient transmembrane transport of potassium ions;Acta Biomaterialia;2024-06

3. Impact of sequential (first- to third-generation) EGFR-TKI treatment on corrected QT interval in NSCLC patients;Frontiers in Oncology;2024-05-07

4. Research Progress on the Cardiotoxicity of EGFR-TKIs in Non-Small Cell Lung Cancer;Current Treatment Options in Oncology;2023-12

5. Gefitinib Increases the Incidence of QT Prolongation in Patients with Non-Small Cell Lung Cancer;International Heart Journal;2023-05-31